title: Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.
authors.affiliation: Amy S. Kehl, MD: University of California at Los Angeles, Santa Monica, California.
authors.forename: Amy S
authors.initials: AS
authors.lastname: Kehl
authors.affiliation: Maripat Corr, MD: University of California at San Diego, La Jolla, California.
authors.forename: Maripat
authors.initials: M
authors.lastname: Corr
authors.affiliation: Michael H. Weisman, MD: Cedars-Sinai Medical Center, Los Angeles, California.
authors.forename: Michael H
authors.initials: MH
authors.lastname: Weisman
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D015551:Autoimmunity; D019485:Bone Morphogenetic Proteins / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D051445:Fibrocartilage / Q000276:immunology; D006801:Humans; D053759:Interleukin-23 / Q000276:immunology*; D007378:Interleukins / Q000276:immunology*; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D000069283:Rituximab / Q000627:therapeutic use; D025242:Spondylarthropathies / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D052256:Tendinopathy / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D053675:Versicans / Q000276:immunology; D000097043:Interleukin-22
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D019485:Bone Morphogenetic Proteins; D016207:Cytokines; D053759:Interleukin-23; D007378:Interleukins; D008727:Methotrexate; D000069283:Rituximab; D013792:Thalidomide; D014409:Tumor Necrosis Factor-alpha; D053675:Versicans; D000097043:Interleukin-22; C505730:apremilast